Nemec Sarah, Senior VP of Finance and PAO at Bolt Biotherapeutics ($BOLT), made two open market purchases of company shares in the last year, totaling $1,262. Her most recent buy occurred on December 5, 2025. These purchases rank 4,797th among 4,983 insiders in our database, where the average buy amount is $1.46 million across 3.29 transactions. Sarah Nemec reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | P | Common Stock | 125 | $4.61 | 1,415.0000 | 1,919,441 | 9.69% | 0.01% |
| Jan. 28, 2026 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 8000 | $0.00 | 8,000.0000 | 1,919,441 | 9999.99% | 0.42% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 2199 | $0.00 | 2,199.0000 | 1,919,441 | 9999.99% | 0.11% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 1589 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.08% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 2499 | $0.00 | 2,499.0000 | 1,919,441 | 9999.99% | 0.13% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 2499 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.13% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 4499 | $0.00 | 4,499.0000 | 1,919,441 | 9999.99% | 0.23% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 4499 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.23% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 11299 | $0.00 | 11,299.0000 | 1,919,441 | 9999.99% | 0.59% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 11299 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.59% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 1236 | $0.00 | 1,236.0000 | 1,919,441 | 9999.99% | 0.06% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 1236 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.06% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 375 | $0.00 | 375.0000 | 1,919,441 | 9999.99% | 0.02% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 375 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.02% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 600 | $0.00 | 600.0000 | 1,919,441 | 9999.99% | 0.03% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 600 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.03% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 2199 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.11% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 6699 | $0.00 | 6,699.0000 | 1,919,441 | 9999.99% | 0.35% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | D | Employee Stock Option (Right to Buy) | 6699 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.35% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Employee Stock Option (Right to Buy) | 1589 | $0.00 | 1,589.0000 | 1,919,441 | 9999.99% | 0.08% |
| Oct. 22, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Common Stock | 23000 | $0.00 | 23,943.0000 | 38,339,697 | 2439.02% | 0.06% |
| June 6, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | P | Common Stock | 125 | $5.49 | 943.0000 | 38,339,697 | 15.28% | 0.00% |
| May 1, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | A | Stock Option (Right to Buy) | 226000 | $0.00 | 226,000.0000 | 38,339,697 | 9999.99% | 0.59% |
| Dec. 16, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | P | Common Stock | 2500 | $0.50 | 16,633.0000 | 0 | 17.69% | 0.00% |
| June 6, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | Senior VP, Finance and PAO | P | Common Stock | 2500 | $0.64 | 13,863.0000 | 0 | 22.00% | 0.00% |
| July 23, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | VP, Finance and PAO | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| July 23, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | Nemec Sarah | VP, Finance and PAO | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |